MDT · News · 20261012N

Competition and Market Position

Medtronic plc · 2026-10-12 · Importance 31 · Surprise 42 · In source text

Stryker is entering soft-tissue surgical robotics through a $400 million investment in CMR Surgical. The arrangement makes Stryker the exclusive U.S. distributor of CMR’s Versius robotic system, positioning it against Medtronic, Johnson & Johnson, and Intuitive Surgical. Versius is already cleared in the United States for gallbladder procedures and may initially target lower-cost facilities such as ambulatory surgery centers while expanding to additional indications.

Key facts

• Medtronic's fiscal first-quarter 2027 revenue reached USD 9.756 billion. source
• Medtronic's exchange offer being oversubscribed and the split-off completion was cited as a primary driver of a 3.36% rise in Medtronic PLC stock on October 12, 2026. source
• Medtronic PLC stock increased by 3.90% to $91.93 on Monday, marking the third consecutive day of gains. source
• Medtronic stock rose approximately 3% to about $91 in the pre-market session on the day the exchange offer news circulated. source
• Market commentary linked Medtronic's stock advance to new CPT codes, FDA clearances, completion of the diabetes split-off, and strong R&D investment. source
• One report said Medtronic continues to invest heavily in R&D. source
• Medtronic's stock was trading at EUR 78.99, up 0.91 percent. source
• Commentary noted Barclays maintained an 'Equal Weight' rating on Medtronic while highlighting R&D investment and patient reach in Medtronic's FY26 Impact Report. source

Impact estimates